Janette Naines, CCA, CRIS’ Post

So, I am back from JPM Healthcare conference in SanFran.  It was a crazy week and a great experience. My 5 takeaways: (1) It is THE place to be for Pharma / Biotech partnering (2) Specifically for publicly traded organisations, presenting your company at the conference is a must to enforce your relevancy (3) The action is outside of the actual conference - majority of people don’t attend the conference but rather meet for business development, investment, or company analysis (4) Getting invited and attending the right evening receptions is even more critical than formal meetings. I had five receptions in one evening - could only make 3 of the 5 but they were worth it. (5) And MOST importantly, wear comfortable walking shoes and bring a good umbrella as you are moving between all the various hotels in central SanFran as you race to get to your next meeting. As mentioned previously, our BenevolentAI's Chairman & acting CEO, Francois Nader presented at the conference and did a fabulous job. He even mentioned my name as the Chief Revenue Officer in spearheading our way forward - quite an honour! The link to the recording is below.  In my PoV it is worth 20 minutes of your time. However, if you don't have time here is my recap: We are at the intersection of Pharma & Tech and  a pioneer & leader in AI-augmented drug discovery, enabled by the Benevolent Platform. We stand above our competition of AI in drug discovery as not only have we been doing it for 10 years, but we are also one of the rare platforms that has validated our approach via three ways : (1) Successful collaborations with AstraZeneca with TargetID and most recently Merck Healthcare KGaA with Chemistry. For AstraZeneca the products are in the pipeline and they're real. (2) We leveraged our indication expansion capabilities to identify Eli Lilly and Company's rheumatoid arthritis drug Olumiant (baricitinib) as a potential treatment for COVID-19, which received an emergency use authorisation from the US FDA in 2020; full approval in May 2022. (3) Our platform has generated 5 wholly owned products in a pipeline that looks like a traditional Biotech. Our lead asset BEN-8744 is an oral PDE10 inhibitor in Phase I which is a potential first-in-class option for ulcerative colitis. Our Business model offers multiple routes for value creation. In addition to our high potential R&D pipeline and our leading E2E Drug Discovery solutions mentioned above, we have a new expansion opportunity through suite of Knowledge Exploration tools that acting as a co-pilot for scientists, leverages bio-specific natural language processing (NLP) and large language models (LLM) to surface data, perform analysis, and give scientific recommendations to drive new insights and increase productivity. So, as you can see from above, this is a very exciting time for BenevolentAI and I am thrilled to be part of the journey! #JPM2024 #drugdiscovery #aidrugdiscovery #generativeai #researchanddevelopment

Join me, Jan Chaffey, and Gary Smith AM at the AAPM National Conference to discover how patient feedback can lead to transformative healthcare improvements in primary care. AGPAL & QIP, CFEP Surveys #patientfeedback #quality improvement #primarycare #healthcare #practicemanagement

Are healthcare conferences worth it? 🧐 Hear the tips and strategies that Alan Shoebridge uses to get the most out of an event: https://lnkd.in/eS2PJb6v Providence #SwaayHealth #hcmktg

HCAA members, don't forget to register for the webinar titled "The New, Ethically Transparent World of Healthcare"! Join Mark Galvin to learn how to leverage price transparency compliance and gain invaluable insights into the evolving landscape of the healthcare ecosystem. #pricetransparency #HCAA #healthcare

Gain valuable insights and strategies to build a resilient and thriving healthcare organization for 2025 and beyond. Learn more about this session from Forvis Mazars at the HFMA GHL Fall Conference: https://bit.ly/3zxFhyw

🚨 Exciting News! 🚨 Join Tony Jerald PMP, CISRCP this week at the Washington-Alaska HFMA Fall Conference, happening October 9-10! Tony will be there, ready to discuss how our cutting-edge solutions can help transform your Healthcare IT operations. 💻🔧 If you'd like to set up a meeting with Tony to talk about your specific Healthcare IT needs, drop a comment below or send us a message! #HFMA #HealthcareIT

Gain valuable insights and strategies to build a resilient and thriving healthcare organization for 2025 and beyond. Learn more about this session from Forvis Mazars at the HFMA GHL Fall Conference: https://bit.ly/3zxFhyw

Gain valuable insights and strategies to build a resilient and thriving healthcare organization for 2025 and beyond. Learn more about this session from Forvis Mazars at the HFMA GHL Fall Conference: https://bit.ly/3zxFhyw

Gain valuable insights and strategies to build a resilient and thriving healthcare organization for 2025 and beyond. Learn more about this session from Forvis Mazars at the HFMA GHL Fall Conference: https://bit.ly/3zxFhyw

What is 'quality'? NAHQ campaign aims to standardize definition: The National Association for Healthcare Quality announced a new campaign July 1 aimed at underscoring the importance of the quality at healthcare facilities nationwide.  http://dlvr.it/T920dq